Pathogenic variants in the genes affected in Alport syndrome (COL4A3–COL4A5) and their association with other kidney conditions: a review
Massively parallel sequencing identifies pathogenic variants in the genes affected in Alport
syndrome (COL4A3–COL4A5) in as many as 30% of individuals with focal and segmental …
syndrome (COL4A3–COL4A5) in as many as 30% of individuals with focal and segmental …
[HTML][HTML] Polycystic kidney disease, autosomal dominant
PC Harris, VE Torres - 2018 - europepmc.org
Autosomal dominant polycystic kidney disease (ADPKD) is generally a late-onset
multisystem disorder characterized by bilateral kidney cysts, liver cysts, and an increased …
multisystem disorder characterized by bilateral kidney cysts, liver cysts, and an increased …
Guidelines for genetic testing and management of Alport syndrome
Genetic testing for pathogenic COL4A3–5 variants is usually undertaken to investigate the
cause of persistent hematuria, especially with a family history of hematuria or kidney function …
cause of persistent hematuria, especially with a family history of hematuria or kidney function …
[HTML][HTML] Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: refining the ACMG criteria
J Savige, H Storey, E Watson, JM Hertz… - European journal of …, 2021 - nature.com
Abstract The recent Chandos House meeting of the Alport Variant Collaborative extended
the indications for screening for pathogenic variants in the COL4A5, COL4A3 and COL4A4 …
the indications for screening for pathogenic variants in the COL4A5, COL4A3 and COL4A4 …
[PDF][PDF] Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney-spectrum phenotype
SR Senum, YSM Li, KA Benson, G Joli… - The American Journal of …, 2022 - cell.com
Autosomal dominant polycystic kidney disease (ADPKD), characterized by progressive cyst
formation/expansion, results in enlarged kidneys and often end stage kidney disease …
formation/expansion, results in enlarged kidneys and often end stage kidney disease …
[HTML][HTML] The 2019 and 2021 international workshops on Alport syndrome
In 1927 Arthur Cecil Alport, a South African physician, described a British family with an
inherited form of kidney disease that affected males more severely than females and was …
inherited form of kidney disease that affected males more severely than females and was …
[HTML][HTML] Heterozygous pathogenic COL4A3 and COL4A4 variants (autosomal dominant Alport syndrome) are common, and not typically associated with end-stage …
J Savige - Kidney International Reports, 2022 - Elsevier
The term “autosomal dominant (AD) Alport syndrome” is often used to describe the condition
associated with heterozygous pathogenic COL4A3 or COL4A4 variants and has largely …
associated with heterozygous pathogenic COL4A3 or COL4A4 variants and has largely …
Rare genetic causes of complex kidney and urological diseases
Although often considered a single-entity, chronic kidney disease (CKD) comprises many
pathophysiologically distinct disorders that result in persistently abnormal kidney structure …
pathophysiologically distinct disorders that result in persistently abnormal kidney structure …
[HTML][HTML] Molecular basis, diagnostic challenges and therapeutic approaches of alport syndrome: A primer for clinicians
R Martínez-Pulleiro, M García-Murias… - International journal of …, 2021 - mdpi.com
Alport syndrome is a genetic and hereditary disease, caused by mutations in the type IV
collagen genes COL4A3, COL4A4 and COL4A5, that affects the glomerular basement …
collagen genes COL4A3, COL4A4 and COL4A5, that affects the glomerular basement …
Thin Basement Membrane: An Underrated Cause of End-Stage Renal Disease
M Uzzo, G Moroni, C Ponticelli - Nephron, 2023 - karger.com
The term “thin basement membrane”(TBM) refers to a glomerular disorder characterized by
diffuse uniform thinning of the glomerular basement membrane (GBM) on electron …
diffuse uniform thinning of the glomerular basement membrane (GBM) on electron …